These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36056782)

  • 1. Nineteen months into the pandemic, what have we learned about COVID-19-related outcomes in patients with psoriasis?
    Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Shavit E; Cohen AD
    J Cosmet Dermatol; 2022 Dec; 21(12):6549-6553. PubMed ID: 36056782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.
    Kridin K; Schonmann Y; Damiani G; Peretz A; Onn E; Bitan DT; Cohen AD
    Dermatol Ther; 2021 Jul; 34(4):e15003. PubMed ID: 34033207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study.
    Kridin K; Schonmann Y; Tzur Bitan D; Damiani G; Peretz A; Weinstein O; Cohen AD
    Am J Clin Dermatol; 2021 Sep; 22(5):709-718. PubMed ID: 34060006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
    Mahil SK; Dand N; Mason KJ; Yiu ZZN; Tsakok T; Meynell F; Coker B; McAteer H; Moorhead L; Mackenzie T; Rossi MT; Rivera R; Mahe E; Carugno A; Magnano M; Rech G; Balogh EA; Feldman SR; De La Cruz C; Choon SE; Naldi L; Lambert J; Spuls P; Jullien D; Bachelez H; McMahon DE; Freeman EE; Gisondi P; Puig L; Warren RB; Di Meglio P; Langan SM; Capon F; Griffiths CEM; Barker JN; Smith CH;
    J Allergy Clin Immunol; 2021 Jan; 147(1):60-71. PubMed ID: 33075408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID).
    Kwee KV; Murk JL; Yin Q; Visch MB; Davidson L; de Jong EMGJ; van den Reek JMPA; Tjioe M
    J Dermatolog Treat; 2023 Dec; 34(1):2161297. PubMed ID: 36545844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study.
    Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Cohen AD
    Am J Clin Dermatol; 2022 May; 23(3):385-392. PubMed ID: 35294720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis.
    Liu M; Wang H; Liu L; Cui S; Huo X; Xiao Z; Zhao Y; Wang B; Zhang G; Wang N
    Front Immunol; 2022; 13():1046352. PubMed ID: 36389759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.
    Penso L; Dray-Spira R; Weill A; Zureik M; Sbidian E
    Br J Dermatol; 2022 Jan; 186(1):59-68. PubMed ID: 34310699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China.
    Liu Y; Xu Z; Zhou J; Chen A; Zhang J; Kang X; Jiang X; Lyu C; Shi C; Shi Y; Liu X; Li F; Yang B; Huang Y; Yu C; Wang G
    Chin Med J (Engl); 2024 Jul; 137(14):1736-1743. PubMed ID: 38710539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
    Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
    JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
    Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study.
    Richard L; Booth R; Rayner J; Clemens KK; Forchuk C; Shariff SZ
    CMAJ Open; 2021; 9(1):E1-E9. PubMed ID: 33436450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
    Nordström P; Ballin M; Nordström A
    Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe COVID-19 infection in persons with diabetes during the first and second waves in Denmark: A nationwide cohort study.
    Stidsen JV; Green A; Rosengaard L; Højlund K
    Front Endocrinol (Lausanne); 2022; 13():1025699. PubMed ID: 36303877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
    Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
    JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
    Shi Q; Zhang X; Jiang F; Zhang X; Hu N; Bimu C; Feng J; Yan S; Guan Y; Xu D; He G; Chen C; Xiong X; Liu L; Li H; Tao J; Peng Z; Wang W
    Diabetes Care; 2020 Jul; 43(7):1382-1391. PubMed ID: 32409504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis.
    Gisondi P; Geat D; Bellinato F; Girolomoni G
    Expert Opin Biol Ther; 2022 Dec; 22(12):1521-1529. PubMed ID: 35930356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study.
    Kridin K; Schonmann Y; Solomon A; Onn E; Bitan DT; Weinstein O; Cohen AD
    Immunol Res; 2022 Feb; 70(1):106-113. PubMed ID: 34647194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study.
    Omrani AS; Almaslamani MA; Daghfal J; Alattar RA; Elgara M; Shaar SH; Ibrahim TBH; Zaqout A; Bakdach D; Akkari AM; Baiou A; Alhariri B; Elajez R; Husain AAM; Badawi MN; Abid FB; Abu Jarir SH; Abdalla S; Kaleeckal A; Choda K; Chinta VR; Sherbash MA; Al-Ismail K; Abukhattab M; Ait Hssain A; Coyle PV; Bertollini R; Frenneaux MP; Alkhal A; Al-Kuwari HM
    BMC Infect Dis; 2020 Oct; 20(1):777. PubMed ID: 33076848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.